Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis

Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis

Head and neck squamous cell carcinoma (HNSCC) accounts for approximately 3% of new cancer cases and 3% of all deaths worldwide. Most HNSCC patients are locally advanced (LA) at diagnosis. The combination of radiotherapy (RT), chemotherapy, targeted therapy, and immunotherapy are the primary LA-HNSCC...

Full description

Bibliographic Details
Main Authors: Huanhuan Wang, Zhuangzhuang Zheng, Yangyu Zhang, Chenbin Bian, Jindian Bao, Ying Xin, Xin Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pharmacology
Subjects:
locally advanced head and neck squamous cell carcinoma
meta-analysis
concurrent chemo-radiotherapy
radiotherapy
accelerated fractionated radiotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1269863/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1269863/full

Similar Items